| Title: |
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study |
| Authors: |
van de Donk, Niels W. C. J.Aff1, IDs41408024011601_cor1; Bahlis, NizarAff2; Costa, Luciano J.Aff3; Mateos, María-VictoriaAff4; Nooka, Ajay K.Aff5; Perrot, AuroreAff6; Garfall, Alfred L.Aff7; Thaman, PragyaAff8; Qi, KeqinAff9; Uhlar, ClarissaAff10; Chastain, KatherineAff11; Doyle, MargaretAff12; Usmani, Saad Z.Aff13 |
| Source: |
Blood Cancer Journal. 14(1) |
| Database: |
Springer Nature Journals |